Authors: Maria Jose Almada, Bruno Forti, Patricia Murina, Carlos Daniel Venencia
Affiliation: Instituto Zunino - Fundacion Marie Curie, Dra.
Abstract Preview: Purpose: The use of VMAT for the breast requires duplication of the patient's CT, several planning structures, and patient-specific dose-volume constraints depending on the patient's anatomy, fraction...
Authors: Thomas L. Hayes, Nicholas C. Koch, Han Liu, Qingyang (Grace) Shang, Benjamin J. Sintay, Caroline Vanderstraeten, David B. Wiant
Affiliation: Fuse Oncology, Cone Health, Cone Health Cancer Center
Abstract Preview: Purpose:
This study evaluates the accuracy of a deep learning-based automatic breast planning script in predicting beam energy for breast cancer treatments. The script was validated and implemented...
Authors: Maria Jose Almada, Oscar Apaza, Carlos Bohorquez, Ezequiel Cabrera, Rogelio Diaz Moreno, Maximiliano Musso, Rosa Petit, Carlos Daniel Venencia, Lucy D. Wolfsberger
Affiliation: LAP, FaMAF, UNC, Instituto Zunino - Fundacion Marie Curie
Abstract Preview: Purpose:
PSQA employs gamma analysis to verify the planned versus delivered dose. Evaluating the effectiveness of PSQA techniques in identifying errors is crucial. This study aims to incorporate ML...
Authors: Alison Amos, Alan H. Baydush, Shawna Buchanan, Nicole Carone, Sarah Cummings, Corey Henderson, Christy Hickerson, Gretchen Kessler, Sydney Lash, Kelli Reardon, Michelle Rokni, Sarah B. Wisnoskie, Ashlyn Zebrowski
Affiliation: UNC-Chapel Hill, UNC Chapel HIll, Novant Health
Abstract Preview: Purpose: As Medical Physics 3.0 (MP3.0) progresses, many clinics are integrating consultations with physicists to educate cancer patients, reduce stress, and enhance the patient experience. However, d...
Authors: Laura Buchanan, Samantha G. Hedrick, Stephen L. Mahan, Isabella Pfeiffer, Chester R. Ramsey
Affiliation: Thompson Proton Center
Abstract Preview: Purpose: Linear energy transfer (LET) and variable relative biological effectiveness (RBE) evaluation are important steps in the future of proton therapy, moving beyond RBE=1.1 for all treatment plann...